The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis

European Journal of Biochemistry

Volumn 246, Issue 3, 1997, Pages 581-601

  Herwig, Susanne ^a   Strauss, Michael ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Apoptosis; Cell cycle; Differentiation; Restriction point; Retinoblastoma

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; RETINOBLASTOMA; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030991235     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.t01-2-00581.x     Document Type: Review

References (389)

1. Aagaard, L., Lukas, J., Bartkova, J., Kjerulff, A. A., Strauss, M. & Bartek, J. (1995) Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines, Int. J. Cancer 61, 115-120.
2. Abramson, D. H., Ronner, H. J. & Ellsworth, R. M. (1979) Second tumors in nonirradiated bilateral retinoblastoma, Am. J. Ophthalmol. 87, 624-627.
3. Adnane, J. & Robbins, P. D. (1995) The retinoblastoma susceptibility gene product regulates Myc-mediated transcription, Oncogene 10, 381-387.
4. Al Ubaidi, M. R., Hollyfield, J. G., Overbeek, P. A. & Baehr, W. (1992) Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice, Proc. Natl Acad. Sci. USA 89, 1194-1198.
5. Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li, W., Bertino, J. R. & Wahl, G. M. (1995) Deficiency of retinoblastoma protein leads to inappropriate S phase entry, activation of E2F-responsive genes, and apoptosis, Proc. Natl Acad. Sci. USA 92, 5436-5440.
6. Bagchi, S., Weinmann, R. & Raychaudhuri, P. (1991) The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F, Cell 65, 1063-1072.
7. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M. & Draetta, G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1, Genes & Dev. 7, 812-821.
8. Bandara, L. R. & LaThangue, N. B. (1991) Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor, Nature 351, 494-497.
9. Bandara, L. R., Adamczewski, J. P., Hunt, T. & LaThangue, N. B. (1991) Cyclin A and the retinoblastoma gene product complex with a common transcription factor, Nature 352, 249-251.
10. Bandara, L. R., Buck, V. M., Zamanian, M., Johnston, L. H. & LaThangue, N. B. (1993) Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F, EMBO J. 12, 4317-4324.
11. Bartkova, J., Lukas, J., Müller, H., Lutzhoft, D., Strauss, M. & Bartek, J. (1994a) Cyclin D1 protein expression and function in human breast cancer, Int. J. Cancer 57, 353-361.
12. Bartkova, J., Lukas, J., Strauss, M. & Bartek, J. (1994b) The PRAD-1/ cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas, Int. J. Cancer 58, 568-573.
13. Baskaran, R., Dahmus, M. E. & Wang, J. Y. (1993) Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain, Proc. Natl Acad. Sci. USA 90, 11 167-11 171.
14. Bates, S., Bonetta, L., Mac-Allan, D., Parry, D., Holder, A., Dickson, C. & Peters, G. (1994) CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1, Oncogene 9, 71-79.
15. Beijersbergen, R. L., Kerkhoven, R. M., Zhu, L., Carlee, L., Voorhoeve, P. M. & Bernards, R. (1994) E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo, Genes & Dev. 8, 2680-2690.
16. Berry, D. E., Lu, Y., Schmidt, B., Fallon, P. G., O'Connell, C., Hu, S. X., Xu, H. J. & Blanck, G. (1996) Retinoblastoma protein inhibits IFN-γ induced apoptosis, Oncogene 12, 1809-1819.
17. Bing, A. & Dou, Q. P. (1996) Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate, Cancer Res. 56, 438-442.
18. Bookstein, R., Lee, E. Y., Peccei, A. & Lee, W. H. (1989) Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line, Mol. Cell. Biol. 9, 1628-1634.
19. Bookstein, R., Shew, J. Y., Chen, P. L., Scully, P. & Lee, W. H. (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene, Science 247, 712-715.
20. Bookstein, R. & Lee, W. H. (1991) Molecular genetics of the retinoblastoma suppressor gene, Crit. Rev. Oncog. 2, 211-227.
21. Botz, J., Zerfass Thome, K., Spitkovsky, D., Delius, H., Vogt, B., Eilers, M., Hatzigeorgiou, A. & Jansen Durr, P. (1996) Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter, Mol. Cell. Biol. 16, 3401-3409.
22. Buchkovich, K., Duffy, L. A. & Harlow, E. (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle, Cell 58, 1097-1105.
23. Buckley, M. F., Sweeney, K. J., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K., Musgrove, E. A. & Sutherland, R. L. (1993) Expression and amplification of cyclin genes in human breast cancer, Oncogene 8, 2127-2133.
24. Buyse, I. M., Shao, G. & Huang, S. (1995) The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein, Proc. Natl Acad. Sci. USA 92, 4467-4471.
25. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J. & Kern, S. E. (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma, Nat. Genet. 8, 27-32.
26. Cao, L., Faha, B., Dembski, M., Tsai, L. H., Harlow, E. & Dyson, N. (1992) Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F, Nature 355, 176-179.
27. Cavanaugh, A. H., Hempel, W. M., Taylor, L. J., Rogalsky, V., Todorov, G. & Rothblum, L. I. (1995) Activity of RNA polymerase 1 transcription factor UBF blocked by Rb gene product, Nature 374, 177-180.
28. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphree, A. L., Strong, L. C. & White, R. L. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma, Nature 305, 779-784.
29. Chan, F. K., Zhang, J., Cheng, L., Shapiro, D. N. & Winoto, A. (1995) Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with similarity to p16ink4, Mol. Cell. Biol. 15, 2682-2688.
30. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M. & Nevins, J. R. (1991) The E2F transcription factor is a cellular target for the RB protein, Cell 65, 1053-1061.
31. Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C. & Nevins, J. R. (1992) Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product, Proc. Natl Acad. Sci. USA 89, 4549-4553.
32. Chen, J., Jackson, P. K., Kirschner, M. W. & Dutta, A. (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA, Nature 374, 386-388.
33. Chen, L. I., Nishinaka, T., Kwan, K., Kitabayashi, I., Yokoyama, K., Fu, Y. H., Grunwald, S. & Chiu, R. (1994) The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator, Mol. Cell. Biol. 14, 4380-4389.
34. Chen, P. L., Scully, P., Shew, J. Y., Wang, J. Y. & Lee, W. H. (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation, Cell 58, 1193-1198.
35. Chen, P. L., Riley, D. J., Chen Kiang, S. & Lee, W. H. (1996) Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6, Proc. Natl Acad. Sci. USA 93, 465-469.
36. Chittenden, T., Livingston, D. M. & Kaelin, W. G. (1991) The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein, Cell 65, 1073-1082.
37. Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M., van der Valk, M., Hooper, M. L., Berns, A. & ter Riele, H. (1992) Requirement for a functional Rb1 gene in murine development, Nature 359, 328-330.
38. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. & Wyllie, A. H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature 362, 849-852.
39. Coats, S., Flanagan, W. M., Nourse, J. & Roberts, J. M. (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle, Science 272, 877-880.
40. Cobrinik, D., Whyte, P., Peeper, D. S., Jacks, T. & Weinberg, R. A. (1993) Cell cycle-specific association of E2F with the p130 E1A-binding protein, Genes & Dev. 7, 2392-2404.
41. Coppola, J. A., Lewis, B. A. & Cole, M. D. (1990) Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types, Oncogene 5, 1731-1733.
42. Cordon Cardo, C., Latres, E., Drobnjak, M., Oliva, M. R., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F. & Levine, A. J. (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas, Cancer Res. 54, 794-799.
43. Dalton, S. (1992) Cell cycle regulation of the human cdc2 gene, EMBO J. 11, 1797-1804.
44. Debbas, M. & White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B, Genes & Dev. 7, 546-554.
45. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J. Y., Huang, C. M., Lee, W. H., Marsilio, E., Paucha, E. & Livingston, D. M. (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene, Cell 54, 275-283.
46. Demers, G. W., Foster, S. A., Halbert, C. L. & Galloway, D. A. (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7, Proc. Natl Acad. Sci. USA 91, 4382-4386.
47. Devoto, S. H., Mudryj, M., Pines, J., Hunter, T. & Nevins, J. R. (1992) A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex, Cell 68, 167-176.
48. Dou, Q. P., Fridovich Keil, J. L. & Pardee, A. B. (1991) Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase, Proc. Natl Acad. Sci. USA 88, 1157-1161.
49. Dou, Q. P., Zhao, S., Levin, A. H., Wang, J., Helin, K. & Pardee, A. B. (1994) G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter, J. Biol. Chem. 269, 1306-1313.
50. Dou, Q. P., An, B. & Will, P. L. (1995) Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis, Proc. Natl Acatl. Sci. USA 92, 9019-9023.
51. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A. & Weinberg, R. A. (1993) Physical interaction of the retinoblastoma protein with human D cyclins, Cell 73, 499-511.
52. Dryja, T. P., Rapaport, J., McGee, T. L., Nork, T. M. & Schwartz, T. L. (1993) Molecular etiology of low-penetrance retinoblastoma in two pedigrees, Am. J. Hum. Genet. 52, 1122-1128.
53. Dunn, J. M., Phillips, R. A., Becker, A. J. & Gallie, B. L. (1988) Identification of germline and somatic mutations affecting the retinoblastoma gene, Science 241, 1797-1800.
54. Duronio, R. J., Brook, A., Dyson, N. & O'Farrell, P. H. (1996) E2F induced S phase requires cyclin E, Genes & Dev. 10, 2505-2513.
55. Dynlacht, B. D., Flores, O., Lees, J. A. & Harlow, E. (1994) Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes & Dev. 8, 1772-1786.
56. Dyson, N., Buchkovich, K., Whyte, P. & Harlow, E. (1989) The cellular 107 K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus, Cell 58, 249-255.
57. Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B. & Livingston, D. M. (1994) Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor, Genes & Dev. 8, 869-884.
58. El Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. & Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression, Cell 75, 817-825.
59. Endo, T. & Nadal Ginard, B. (1986) Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype, Mol. Cell. Biol. 6, 1412-1421.
60. Endo, T. & Goto, S. (1992) Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen, J. Biochem. (Tokyo) 112, 427-430.
61. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. & Hancock, D. C. (1992) Induction of apoptosis in fibroblasts by c-myc protein, Cell 69 119-128.
62. Ewen, M. E., Xing, Y. G., Lawrence, J. B. & Livingston, D. M. (1991) Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein, Cell 66, 1155-1164.
63. Ewen, M. E., Faha, B., Harlow, E. & Livingston, D. M. (1992) Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins, Science 255, 85-87.
64. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J. & Livingston, D. M. (1993) Functional inxeractions of the retinoblastoma protein with mammalian D-type cyclins, Cell 73, 487-497.
65. Fagan, R., Flint, K. J. & Jones, N. (1994) Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein, Cell 78, 799-811.
66. Faha, B., Ewen, M. E., Tsai, L. H., Livingston, D. M. & Harlow, E. (1992) Interaction between human cyclin A and adenovirus E1A-associated p107 protein, Science 255, 87-90.
67. Faha, B., Harlow, E. & Lees, E. (1993) The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2, J. Virol. 67, 2456-2465.
68. Fakharzadeh, S. S., Trusko, S. P. & George, D. L. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line, EMBO J. 10, 1565-1569.
69. Fan, G., Xu, R., Wessendorf, M. W., Ma, X., Kren, B. T. & Steer, C. J. (1995) Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes, Cell. Growth Differ. 6, 1463-1476.
70. Fan, G., Ma, X., Kren, B. T. & Steer, C. J. (1996) The retinoblastoma gene product inhibits TGF-βeta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells, Oncogene 12, 1909-1919.
71. Field, S. J., Tsai, F. Y., Kuo, F. Zubiaga, A. M., Kaelin, W. G. Jr, Livingston, D. M., Orkin, S. H. & Greenberg, M. E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation, Cell 85, 549-561.
72. Firpo, E. J., Koff, A., Solomon, M. J. & Roberts, J. M. (1994) Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes, Mol. Cell. Biol. 14, 4889-4901.
73. Flemington, E. K., Speck, S. H. & Kaelin, W. G. (1993) E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product, Proc. Natl Acad. Sci. USA 90, 6914-6918.
74. Flores Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M. & Hurwitz, J. (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme, Proc. Natl Acad. Sci. USA 91, 8655-8659.
75. Freeman, R. S., Estus, S. & Johnson, E. M. (1994) Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death, Neuron 12, 343-355.
76. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M. & Dryja, T. P. (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma, Nature 323, 643-646.
77. Friend, S. H., Horowitz, J. M., Gerber, M. R., Wang, X. F., Bogenmann, E., Li, F. P. & Weinberg, R. A. (1987) Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein, Proc. Natl Acad. Sci. USA 84, 9059-9063.
78. Fromm, L., Shawlot, W., Gunning, K., Butel, J. S. & Overbeek, P. A. (1994) The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice, Mol. Cell. Biol. 14, 6743-6754.
79. Fromm, L. & Overbeek, P. A. (1996) Regulation of cyclin and cyclin-dependent kinase gene expression during lens differentiation requires the retinoblastoma protein, Oncogene 12, 69-75.
80. Fueyo, J., Gomez Manzano, C., Yung, W. K., Clayman, G. L., Liu, T. J., Bruner, J., Levin, V. A. & Kyritsis, A. P. (1996) Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells, Oncogene 12, 103-110.
81. Fung, Y. K., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H. & Benedict, W. F. (1987) Structural evidence for the authenticity of the human retinoblastoma gene, Science 236, 1657-1661.
82. Furukawa, Y., Terui, Y., Sakoe, K., Ohta, M. & Saito, M. (1994) The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells, J. Biol. Chem. 269, 26 249-26 258.
83. Geng, Y. & Weinberg, R. A. (1993) Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases, Proc. Natl Acad. Sci. USA 90, 10315-10319.
84. Gibson, T. J., Thompson, J. D., Blocker, A. & Kouzarides, T. (1994) Evidence for a protein domain superfamily shared by the cyclins, TFIIB and RB/p107, Nucleic Acids Res. 22, 946-952.
85. Gill, R. M., Hamel, P. A., Zhe, J., Zacksenhaus, E., Gallie, B. L. & Phillips, R. A. (1994) Characterization of the human RB1 promoter and of elements involved in transcriptional regulation, Cell. Growth Differ. 5, 467-474.
86. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D. & Peters, G. (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining, Cancer Res. 54, 1812-1817.
87. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z. X., Xu, G., Wydner, K. L., DeCaprio, J. A., Lawrence, J. B. & Livingston, D. M. (1994) E2F-4, a new member of the E2F transcription factor family, interacts with p107, Genes & Dev. 8, 2665-2679.
88. Giordano, A., McCall, C., Whyte, P. & Franza, B. R. (1991) Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product, Oncogene 6, 481-485.
89. Girling, R., Partridge, J. F., Bandara, L. R., Burden, N., Totty, N. F., Hsuan, J. J. & LaThangue, N. B. (1993) A new component of the transcription factor DRTF1/E2F, Nature 362, 83-87.
90. Goldberg, Y., Nassif, I. I., Pittas, A., Tsai, L. L., Dynlacht, B. D., Rigas, B. & Shiff, S. J. (1996) The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins, Oncogene 12, 893-901.
91. Gonzalez Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M. & Jones, P. A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing, Cancer Res. 55, 4531-4535.
92. Gooding, L. R., Aquino, L., Duerksen Hughes, P. J., Day, D., Horton, T. M., Yei, S. P. & Wold, W. S. (1991) The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells, J. Virol. 65, 3083-3094.
93. Goodrich, D. W., Wang, N. P., Qian, Y. W., Lee, E. Y. & Lee, W. H. (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle, Cell 67, 293-302.
94. Goodrich, D. W. & Lee, W. H. (1993) Molecular characterization of the retinoblastoma susceptibility gene, Biochim. Biophys. Acta 1155, 43-61.
95. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V. & Nadal Ginard, B. (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation, Cell 72, 309-324.
96. Gu, Y., Turck, C. W. & Morgan, D. O. (1993) Inhibition of CDK2 activity in vivo by an associated 20 K regulatory subunit, Nature 366, 707-710.
97. Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G. & Xiong, Y. (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inbibitor, correlates with wild-type pRb function, Genes & Dev. 8, 2939-2952.
98. Guo, K., Wang, J., Andres, V., Smith, R. C. & Walsh, K. (1995) MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation, Mol. Cell. Biol. 15, 3823-3829.
99. Guy, C. T., Zhou, W., Kaufman, S. & Robinson, M. O. (1996) E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes, Mol. Cell. Biol. 16, 685-693.
100. Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., T'Ang, A., Fung, Y. K. & Israel, M. A. (1995) Inhibition of apoptosis by the retinoblastoma gene product, EMBO J. 14, 461-472.
101. Hagemeier, C., Bannister, A. J., Cook, A. & Kouzarides, T. (1993) The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB, Proc. Natl Acad. Sci. USA 90, 1580-1584.
102. Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneman, V. E., Longthorne, V., Culhane, A. C. & Williams, G. T. (1996) Apoptosis: molecular regulation of cell death, Eur. J. Biochem. 236, 1-26
103. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D. & Lassar, A. B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD, Science 267, 1018-1021.
104. Hanna, Z., Jankowski, M., Tremblay, P., Jiang, X., Milatovich, A., Francke, U. & Jolicoeur, P. (1993) The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2, Oncogene 8, 1661-1666.
105. Hannon, G. J., Demetrick, D. & Beach, D. (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins, Genes & Dev. 7, 2378-2391.
106. Hannon, G. J. & Beach, D. (1994) p15INK4B is a potential effector of TGF-β-induced cell cycle arrest, Nature 371, 257-261.
107. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S. & Peters, G. (1996) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence, Mol. Cell. Biol. 16, 859-867.
108. Harbour, J. W., Lai, S. L., Whang Peng, J., Gazdar, A. F., Minna, J. D. & Kaye, F. J. (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC, Science 241, 353-357.
109. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell 75, 805-816.
110. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., Fox, M. P. & Wie, N. (1995) Inhibition of cyclin-dependent kinases by p21, Mol. Biol. Cell. 6, 387-400.
111. Hartwell, L. H. & Kastan, M. B. (1994) Cell cycle control and cancer, Science 266, 1821-1828.
112. Hashimoto, S., Ishii, A. & Yonehara, S. (1991) The E1β oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody, Int. Immunol 3, 343-351.
113. Hatakeyama, M., Brill, J. A., Fink, G. R. & Weinberg, R. A. (1994) Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein, Genes & Dev. 8, 1759-1771.
114. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H. & Oren, M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53, Genes & Dev. 9, 2170-2183.
115. He, J., Allen, J. R., Collins, V. P., Allalunis Turner, M. J., Godbout, R., Day, R. S. 3rd & James, C. D. (1994) CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines, Cancer Res. 54, 5804-5807.
116. Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E. & Fattaey, A. (1992) A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F, Cell 70, 337-350.
117. Helin, K., Harlow, E. & Fattaey, A. (1993a) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein, Mol. Cell. Biol. 13, 6501-6508.
118. Helin, K., Wu, C. L., Fattaey, A. R., Lees, J. A., Dynlacht, B. D., Ngwu, C. & Harlow, E. (1993b) Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation, Genes & Dev. 7, 1850-1861.
119. Hendricks Taylor, L. R. & Darlington, G. J. (1995) Inhibition of cell proliferation by C/EBP α occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen, Nucleic Acids Res. 23, 4726-4733.
120. Henglein, B., Chenivesse, X., Wang, J., Eick, D. & Brechot, C. (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene, Proc. Natl Acad Sci. USA 91, 5490-5494.
121. Hensey, C. E., Hong, F., Durfee, T., Qian, Y. W., Lee, E. Y. & Lee, W. H. (1994) Identification of discrete structural domains in the retinoblastoma protein. Amino-terminal domain is required for its oligomerization, J. Biol. Chem. 269, 1380-1387.
122. Herber, B., Truss, M., Beato, M. & Müller, R. (1994) Inducible regulatory elements in the human cyclin D1 promoter, Oncogene 9, 1295-1304.
123. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D. & Baylin, S. B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res. 55, 4525-4530.
124. Herrera, R. E., Sah, V. P., Williams, B. O., Makela, T. P., Weinberg, R. A. & Jacks, T. (1996) Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts, Mol. Cell. Biol. 16, 2402-2407.
125. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M. & Nevins, J. R. (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F, Genes & Dev. 6, 177-185.
126. Hiebert, S. W. (1993) Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression, Mol. Cell. Biol. 13, 3384-3391.
127. Hijmans, E. M., Voorhoeve, P. M., Beijersbergen, R. L., van't Veer, L. J. & Bernards, R. (1995) E2F-5, a new E2F family member that interacts with p130 in vivo, Mol. Cell. Biol. 15, 3082-3089.
128. Hirai, H., Roussel, M. F., Kato, J. Y., Ashmun, R. A. & Sherr, C. J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6, Mol. Cell. Biol. 15, 2672-2681.
129. Hirama, T. & Koeffler, H. P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer, Blood 86, 841-854.
130. Hoang, A. T., Cohen, K. J., Barrett, J. F., Bergstrom, D. A. & Dang, C. V. (1994) Participation of cyclin A in Myc-induced apoptosis, Proc. Natl Acad. Sci. USA 91, 6875-6879.
131. Hogg, A., Bia, B., Onadim, Z. & Cowell, J. K. (1993) Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma, Proc. Natl Acad. Sci. USA 90, 7351-7355.
132. Hong Wang, R. J. & Milner, A. E. (1996) Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein, Oncogene 31, 372-319.
133. Horowitz, J. M., Park, S. H., Bogenmann, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P. & Weinberg, R. A. (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells, Proc. Natl Acad. Sci. USA 87, 2775-2779.
134. Howe, J. A. & Bayley, S. T. (1992) Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A, Virology 186, 15-24.
135. Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M. & Windle, J. J. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53, Genes & Dev. 8, 1300-1310.
136. Hsiao, K. M., McMahon, S. L. & Farnham, P. J. (1994) Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter, Genes & Dev. 8, 1526-1537.
137. Hu, Q. J., Dyson, N. & Harlow, E. (1990) The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations, EMBO J. 9, 1147-1155.
138. Huang, H. J., Yee, J. K., Shew, J. Y., Chen, P. L., Bookstein, R., Friedmann, T., Lee, E. Y. & Lee, W. H. (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells, Science 242, 1563-1566.
139. Huang, S., Wang, N. P., Tseng, B. Y., Lee, W. H. & Lee, E. H. (1990) Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen, EMBO J. 9, 1815-1822.
140. Huibregtse, J. M., Scheffner, M. & Howley, P. M. (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins, Mol. Cell. Biol. 13, 4918-4927.
141. Hunter, T. & Pines, J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age, Cell 79, 573-582.
142. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. H. Jr, Tucker, M. A. & Dracopoli, N. C. (1994) Germline p16 mutations in familial melanoma, Nat. Genet. 8, 15-21.
143. Iavarone, A., Garg, P., Lasorella, A., Hsu, J. & Israel, M. A. (1994) The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein, Genes & Dev. 8, 1270-1284.
144. Igaki, H., Sasaki, H., Kishi, T., Sakamoto, H., Tachimori, Y., Kato, H., Watanabe, H., Sugimura, T. & Terada, M. (1994) Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines, Biochem. Biophys. Res. Commun. 203, 1090-1095.
145. Ikeda, M. A., Jakoi, L. & Nevins, J. R. (1996) A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation, Proc. Natl Acad. Sci. USA 93, 3215-3220.
146. Iujvidin, S., Fuchs, O., Nudel, U. & Yaffe, D. (1990) SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes, Differentiation 43, 192-203.
147. Ivey Hoyle, M., Conroy, R., Huber, H. E., Goodhart, P. J., Oliff, A. & Heimbrook, D. C. (1993) Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F, Mol. Cell. Biol. 13, 7802-7812.
148. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A. & Weinberg, R. A. (1992) Effects of an Rb mutation in the mouse, Nature 359, 295-300.
149. Jiang, W., Kahn, S. M., Tomita, N., Zhang, Y. J., Lu, S. H. & Weinstein, I. B. (1992) Amplification and expression of the human cyclin D gene in esophageal cancer, Cancer Res. 52, 2980-2983.
150. Jiang, W., Kahn, S. M., Zhou, P., Zhang, Y. J., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M. & Weinstein, I. B. (1993a) Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression, Oncogene 8, 3447-3457.
151. Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R. & Weinstein, I. B. (1993b) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer, Proc. Natl Acad. Sci. USA 90, 9026-9030.
152. Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E. & Fisher, P. B. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53, Oncogene 9, 3397-3406.
153. Johnson, D. G., Schwarz, J. K., Cress, W. D. & Nevins, J. R. (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature 365, 349-352.
154. Johnson, D. G., Ohtani, K. & Nevins, J. R. (1994a) Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression, Genes & Dev. 8, 1514-1525.
155. Johnson, D. G., Cress, W. D., Jakoi, L. & Nevins, J. R. (1994b) Oncogenic capacity of the E2F1 gene, Proc. Natl Acad. Sci. USA 91, 12823-12827.
156. Joseph, L. F., Ezhevsky, S. & Scott, D. W. (1995) Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1, Cell. Growth Differ. 6, 51-57.
157. Kaelin, W. G. Jr, Ewen, M. E. & Livingston, D. M. (1990) Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product, Mol. Cell. Biol. 10, 3761-3769.
158. Kaelin, W. G. Jr, Pallas, D. C., DeCaprio, J. A., Kaye, F. J. & Livingston, D. M. (1991) Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product, Cell 64, 521-532.
159. Kaelin, W. G. Jr. Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li. Y., Farnham, P. J., Blanar, M. A., Livingston, D. M. & Flemington, E. K. (1992) Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties, Cell 70, 351-364.
160. Kalman, D., Whittaker, K., Bishop, J. M. & O'Lague, P. H. (1993) Domains of E1A that bind p105Rb, p130, and p300 are required to block nerve groth factor-induced neunte growth in PC12 cells, Mol. Biol. Cell. 4, 353-361.
161. Kamb, A., Gruis, N. A., Weaver Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. 3rd, Johnson, B. E. & Skolnick,
162. Kamb, A. (1995) Cell-cycle regulators and cancer, Trends Genet. 11, 136-140.
163. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E. & Sherr, C. J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4, Genes & Dev. 7, 331-342.
164. Kearsey, J. M., Coates, P. J., Prescott, A. R., Warbrick, E. & Hall, P. A. (1995) Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1, Oncogene 11, 1675-1683.
165. Khatib, Z. A., Matsushime, H., Valentine, M., Shapiro, D. N., Sherr, C. J. & Look, A. T. (1993) Coamplification of the CDK4 gene with MDM2 and GL1 in human sarcomas, Cancer Res. 53, 5535-5541.
166. Kim, S. J., Lee, H. D., Robbins, P. D., Busam, K., Sporn, M. B. & Roberts, A. B. (1991) Regulation of transforming growth factor β 1 gene expression by the product of the retinoblastoma-susceptibility gene, Proc. Natl Acad. Sci. USA 88, 3052-3056.
167. Kim, S. J., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R. & Robbins, P. D. (1992a) The retinoblastoma gene product regulates Sp1-mediated transcription, Mol. Cell. Biol. 12, 2455-2463.
168. Kim, S. J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D. & Green, M. R. (1992b) Retinoblastoma gene product activates expression of the human TGF-β 2 gene through transcription factor ATF-2, Nature 358, 331-334.
169. Kim, T. A., Ravitz, M. J. & Wenner, C. E. (1994) Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts, J. Cell Physiol. 160, 1-9.
170. Kingsley, C. & Winoto, A. (1992) Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression, Mol. Cell. Biol. 12, 4251-4261.
171. Kipreos, E. T. & Wang, J. Y. (1992) Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA, Science 256, 382-385.
172. Knudson, A. G. (1971) Mutation and cancer: statistical study of retinoblastoma, Proc. Natl Acad. Sci. USA 68, 820-823.
173. Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition, Nature 375, 506-510.
174. Kouzarides, T. (1995) Transcriptional control by the retinoblastoma protein, Semin. Cancer Biol. 6, 91-98.
175. Kovesdi, I., Reichel, R. & Nevins, J. R. (1986) Identification of a cellular transcription factor involved in E1A trans-activation, Cell 45, 219-228.
176. Kowalik, T. F., DeGregori, J., Schwarz, J. K. & Nevins, J. R. (1995) E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis, J. Virol. 69, 2491-2500.
177. Kranenburg, O., van der Eb, A. J. & Zantema, A. (1996) Cyclin D1 is an essential mediator of apoptotic neuronal cell death, EMBO J. 15, 46-54.
178. Krek, W., Livingston, D. M. & Shirodkar, S. (1993) Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members, Science 262, 1557-1560.
179. Krek, W., Ewen, M. E., Shirodkar, S., Arany, Z., Kaelin, W. G. Jr & Livingston, D. M. (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase, Cell 78, 161-172.
180. LaThangue, N. B. (1994) DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control, Curr. Opin. Cell. Biol. 6, 443-450.
181. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massague, J. (1990) Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation, Cell 62, 175-185.
182. Lam, E. W., Morris, J. D., Davies, R., Crook, T., Watson, R. J. & Vousden, K. H. (1994) HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes, EMBO J. 13, 871-878.
183. Lammie, G. A. & Peters, G. (1991) Chromosome 11q13 abnormalities in human cancer, Cancer Cells, 3, 413-420.
184. Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A. & Peters, G. (1991) D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1, Oncogene 6, 439-444.
185. Lane, D. P. & Crawford, L. V. (1979) T antigen is bound to a host protein in SV40-transformed cells, Nature 278, 261-263.
186. Lasorella, A., Iavarone, A. & Israel, M. A. (1996) Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins, Mol. Cell. Biol. 16, 2570-2578.
187. Latham, K. M., Eastman, S. W., Wong, A. & Hinds, P. W. (1996) Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases, Mol. Cell. Biol. 16, 4445-4455.
188. Leach, F. S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J. D., Smith, S., Hill, D. E., Sidransky, D., Kinzler, K. W. & Vogelstein, B. (1993a) p53 Mutation and MDM2 amplification in human soft tissue sarcomas, Cancer Res. 53, 2231-2234.
189. Leach, F. S., Elledge, S. J., Sherr, C. J., Willson, J. K., Markowitz, S., Kinzler, K. W. & Vogelstein, B. (1993b) Amplification of cyclin genes in colorectal carcinomas, Cancer Res. 53, 1986-1989.
190. Lee, E. Y., To. H., Shew, J. Y., Bookstein, R., Scully, P. & Lee, W. H. (1988) Inactivation of the retinoblastoma susceptibility gene in human breast cancers, Science 241, 218-221.
191. Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H. & Bradley, A. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis, Nature 359, 288-294.
192. Lee, E. Y., Hu, N., Yuan, S. S., Cox, L. A., Bradley, A., Lee, W. H. & Herrup, K. (1994a) Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation, Genes & Dev. 8, 2008-2021.
193. Lee, J. M., Abrahamson, J. L., Kandel, R., Donehower, L. A. & Bernstein, A. (1994b) Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice, Oncogene 9, 3731-3736.
194. Lee, H. H., Chiang, W. H., Chiang, S. H., Liu, Y. C., Hwang, J. & Ng, S. Y. (1995a) Regulation ofcyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle, Gene Expr. 4, 95-109.
195. Lee, M. H., Reynisdottir, I. & Massague, J. (1995b) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution, Genes & Dev. 9, 639-649.
196. Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y. & Lee, E. Y. (1987a) Human retinoblastoma susceptibility gene: cloning, identification, and sequence, Science 235, 1394-1399.
197. Lee, W. H., Shew, J. Y., Hong, F. D., Sery, T. W., Donoso, L. A., Young, L. J., Bookstein, R. & Lee, E. Y. (1987b) The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity, Nature 329, 642-645.
198. Lees, E., Faha, B., Dulic, V., Reed, S. I. & Harlow, E. (1992) Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner, Genes & Dev. 6, 1874-1885.
199. Lees, J. A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N. & Helin, K. (1993) The retinoblastoma protein binds to a family of E2F transcription factors, Mol. Cell. Biol. 13, 7813-7825.
200. Li, H., Kawasaki, H., Nishida, E., Hattori, S. & Nakamura, S. (1996) Ras-regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells, J. Neurochem. 66, 2287-2294.
201. Li, W., Fan, J., Hochhauser, D., Banerjee, D., Zielinski, Z., Almasan, A., Yin, Y., Kelly, R., Wahl, G. M. & Bertino, J. R. (1995) Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines, Proc. Natl Acad. Sci. USA 92, 10 436-10 440.
202. Li, Y., Graham, C., Lacy, S., Duncan, A. M. & Whyte, P. (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E, Genes & Dev. 7, 2366-2377.
203. Li, Y., Jenkins, C. W., Nichols, M. A. & Xiong, Y. (1994) Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21, Oncogene 9, 2261-2268.
204. Linzer, D. I. & Levine, A. J. (1979) Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell 17, 43-52.
205. Liu, M., Lee, M. H., Cohen, M., Bommakanti, M. & Freedman, L. P. (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937, Genes & Dev. 10, 142-153.
206. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. & Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes, Nature 362, 847-849.
207. Ludlow, J. W., DeCaprio, J. A., Huang, C. M., Lee, W. H., Paucha, E. & Livingston, D. M. (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family, Cell 56, 57-65.
208. Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen Durr, P., Strauss, M. & Bartek, J. (1994a) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1, J. Cell. Biol. 125, 625-638.
209. Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. (1994b) Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines, Oncogene 9, 707-718.
210. Lukas, J., Jadayel, D., Bartkova, J., Nacheva, E., Dyer, M. J., Strauss, M. & Bartek, J. (1994c) BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation, Oncogene 9, 2159-2167.
211. Lukas, J., Bartkova, J., Rohde, M., Strauss, M. & Bartek, J. (1995a) Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity, Mol. Cell. Biol. 15, 2600-2611.
212. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G. & Bartek, J. (1995b) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16, Nature 375, 503-506.
213. Lukas, J., Aagaard, L., Strauss, M. & Bartek, J. (1995c) Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control, Cancer Res. 55, 4818-4823.
214. Lukas, J., Bartkova, J. & Bartek, J. (1996) Convergence of mitogenic signalling cascades from diverse classes of receptors on the cyclin D/cdk-pRB-controlled G1 checkpoint, Mol. Cell. Biol. 16, 6917-6925.
215. Luo, Y., Hurwitz, J. & Massague, J. (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1, Nature 375, 159-161.
216. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. & Jacks, T. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage, Genes & Dev. 9, 935-944.
217. Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W. & Elledge, S. J. (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene, Genes & Dev. 9, 650-662.
218. Matsushime, H., Roussel, M. F., Ashmun, R. A. & Sherr, C. J. (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle, Cell 65, 701-713.
219. Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J. Y., Hanks, S. K., Roussel, M. F. & Sherr, C. J. (1992) Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins, Cell 71, 323-334.
220. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J. & Kato, J. Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells, Mol. Cell. Biol. 14, 2066-2076.
221. McCarthy, S. A., Symonds, H. S. & Van Dyke, T. (1994) Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53, Proc. Natl Acad. Sci. USA 91, 3979-3983.
222. Medema, R. H., Herrera, R. E., Lam, F. & Weinberg, R. A. (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein, Proc. Natl Acad. Sci. USA 92, 6289-6293.
223. Meyerson, M. & Harlow, E. (1994) Identification of G1 kinase activity for cdk6, a novel cyclin D partner, Mol. Cell. Biol. 14, 2077-2086.
224. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. & Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway, Cancer Res. 54, 3391-3395.
225. Mihara, K., Cao, X. R., Yen, A., Chandler, S., Driscoll, B., Murphree, A. L., T'Ang, A. & Fung, Y. K. (1989) Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product, Science 246, 1300-1303.
226. Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M. & Dotto, G. P. (1995) Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation, Proc. Natl Acad. Sci. USA 92, 5451-5455.
227. Mistchenko, A. S., Diez, R. A., Romquin, N., Sanceau, J. & Wietzerbin, J. (1993) Interferon-γ modulates retinoblastoma gene mRNA in monocytoid cells, Int. J. Cancer 53, 87-90.
228. Mittnacht, S., Lees, J. A., Desai, D., Harlow, E., Morgan, D. O. & Weinberg, R. A. (1994) Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation, EMBO J. 13, 118-127.
229. Miyashita, T. & Reed, J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell 80, 293-299.
230. Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell 69, 1237-1245.
231. Morgan, D. O. (1995) Principles of CDK regulation, Nature 374, 131-134.
232. Morgenbesser, S. D., Williams, B. O., Jacks, T. & DePinho, R. A. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens, Nature 371, 72-74.
233. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M. & Arnold, A. (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene, Nature 350, 512-515.
234. Motokura, T. & Arnold, A. (1993) PRAD1/cyclin D1 proto-oncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint, Genes Chromosomes Cancer 7, 89-95.
235. Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J. & Nevins, J. R. (1991) Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A, Cell 65, 1243-1253.
236. Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M. & Strauss, M. (1994) Cyclin D1 expression is regulated by the retinoblastoma protein, Proc. Natl Acad. Sci. USA 91, 2945-2949.
237. Müller, R. (1995) Transcriptional regulation during the mammalian cell cycle, Trends Genet. 11, 173-178.
238. Munger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E. & Howley, P. M. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product, EMRO J. 8, 4099-4105.
239. Nakanishi, M., Robetorye, R. S., Pereira Smith, O. M. & Smith, J. R. (1995) The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition, J. Biol. Chem. 270, 17 060-17 063.
240. Neuman, E., Flemington, E. K., Sellers, W. R. & Kaelin, W. G. (1994) Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter, Mol. Cell. Biol 14, 6607-6615.
241. Nevins, J. R. (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins, Science 258, 424-429.
242. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. & Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature 368, 753-756.
243. Noda, A., Ning, Y., Venable, S. F., Pereira Smith, O. M. & Smith, J. R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen, Exp. Cell Res. 211, 90-98.
244. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R. & Roberts, J. M. (1994) Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin, Nature 372, 570-573.
245. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W. & Schulte Hermann, R. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β 1, Proc. Natl Acad. Sci. USA 89, 5408-5412.
246. Ohkubo, Y., Kishimoto, T., Nakata, T., Yasuda, H. & Endo, T. (1994) SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins, Exp. Cell Res. 214, 270-278.
247. Ohtani Fujita, N., Fujita, T., Takahashi, R., Robbins, P. D., Dryja, T. P. & Sakai, T. (1994) A silencer element in the retinoblastoma tumor-suppressor gene, Oncogene 9, 1703-1711.
248. Ohtsubo, M. & Roberts, J. M. (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts, Science 259, 1908-1912.
249. Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M. & Pagano, M. (1995) Human cyclin E, a nuclear protein essential for the Gl-to-S phase transition, Mol. Cell. Biol. 15, 2612-2624.
250. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L. & Vogelstein, B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas, Nature 358, 80-83.
251. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W. & Vogelstein, B. (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53, Nature 362, 857-860.
252. Ormondroyd, E., De la Luna, S. & LaThangue, N. B. (1995) A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle, Oncogene 11, 1437-1446.
253. Oswald, F. Dobner, T. & Lipp, M. (1996) The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle, Mol. Cell. Biol. 16, 1889-1895.
254. Pagano, M., Draetta, G. & Jansen Durr, P. (1992) Association of cdk2 kinase with the transcription factor E2F during S phase, Science 255, 1144-1147.
255. Pan, H. & Griep, A. E. (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development, Genes & Dev. 8, 1285-1299.
256. Pan, H. & Griep, A. E. (1995) Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development, Genes & Dev. 9, 2157-2169.
257. Pardee, A. B. (1974) A restriction point for control of normal animal cell proliferation, Proc. Natl Acad Sci. USA 71, 1286-1290.
258. Pardee, A. B. (1989) G1 events and regulation of cell proliferation, Science 246, 603-608.
259. Park, K., Choe, J., Osifchin, N. E., Templeton, D. J., Robbins, P. D. & Kim, S. J. (1994) The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product, J. Biol. Chem. 269, 6083-6088.
260. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W. & Elledge, S. J. (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells, Science 267, 1024-1027.
261. Parry, D., Bates, S., Mann, D. J. & Peters, G. (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product, EMBO J. 14, 503-511.
262. Pearson, B. E., Nasheuer, H. P. & Wang, T. S. (1991) Human DNA polymerase α gene: sequences controlling expression in cycling and serum-stimulated cells, Mol. Cell. Biol. 11, 2081-2095.
263. Pietenpol, J. A., Munger, K., Howley, P. M., Stein, R. W. & Moses, H. L. (1991) Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor β 1 and by the retinoblastoma gene product, Proc. Natl Acad. Sci. USA 88, 10 227-10 231.
264. Pines, J. & Hunter, T. (1990) Human cyclin A is adenovirus E1 A-associated protein p60 and behaves differently from cyclin B, Nature 346, 760-763.
265. Pines, J. (1995) Cyclins, CDKs and cancer, Semin. Cancer Biol. 6, 63-72.
266. Pollock, P. M., Pearson, J. V. & Hayward, N. K. (1996) Compilation of somatic mutations of the CDKN2 gene in humancancers: non-random distribution of base substitutions, Genes. Chromosomes and Cancer 15, 77-88.
267. Poluha, W., Poluha, D. K., Chang, B. C., Crosbie, N. E., Schönhoff, C. M., Kilpatrick, D. L. & Ross, A. H. (1996) The cyclin dependent kinase inhibitor p21(WAF1) is required for survival of differentiating neuroblastoma cells, Mol. Cell. Biol. 16, 1335-1341.
268. Polyak, K., Lee, M. H., Erdjument Bromage, H., Koff, A., Roberts, J. M., Tempst, P. & Massague, J. (1994a) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell 78, 59-66.
269. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M. & Koff, A. (1994b) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest, Genes & Dev. 8, 9-22.
270. Qian, Y., Luckey, C., Horton, L., Esser, M. & Templeton, D. J. (1992) Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding, Mol. Cell. Biol. 12, 5363-5372.
271. Qin, X. Q., Chittenden, T., Livingston, D. M. & Kaelin, W. G. (1992) Identification of a growth suppression domain within the retinoblas-toma gene product, Genes & Dev. 6, 953-964.
272. Qin, X. Q., Livingston, D. M., Kaelin, W. G. Jr & Adams, P. D. (1994) Deregulated transcription factor E2F-1 expression leads to S phase entry and p53-mediated apoptosis, Proc. Natl Acad. Sci. USA 91, 10918-10922.
273. Qin, X. Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z. & Kaelin, W. G. (1995) The transcription factor E2F-1 is a downstream target of RB action, Mol. Cell. Biol. 15, 742-755.
274. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y. Bar Sagi, D., Roussel, M. F. & Sherr, C. J. (1993) Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts, Genes & Dev. 7, 1559-1571.
275. Raffeld, M. & Jaffe, E. S. (1991) bcl-1, t(11;14), and mantle cell-derived lymphomas, Blood 78, 259-263.
276. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S. & White, E. (1992) The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins, Proc. Natl Acad. Sci. USA 89, 7742-7746.
277. Reed, J. C. (1994) Bcl-2 and the regulation of programmed cell death, J. Cell Biol. 124, 1-6.
278. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E. & Collins, V. P. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations, Cancer Res. 53, 2736-2739.
279. Resnitzky, D., Tiefenbrun, N., Berissi, H. & Kimchi, A. (1992) Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells, Proc. Natl Acad. Sci. USA 89, 402-406.
280. Resnitzky, D., Gossen, M., Bujard, H. & Reed, S. I. (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system, Mol. Cell. Biol. 14, 1669-1679.
281. Richon, V. M., Rifkind, R. A. & Marks, P. A. (1992) Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells, Cell Growth Differ. 3, 413-420.
282. Richon, V. M. & Venta-Perez, G. (1996) Changes in E2F DNA binding activity during induced erythroid differentiation, Cell Growth Differ. 7, 31-42.
283. Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A. & Marks, P. A. (1996) Second generation hybrid polar compounds are potent inducers of transformed cell differentiation, Proc. Natl Acad. Sci. USA 93, 5705-5708.
284. Robbins, P. D., Horowitz, J. M. & Mulligan, R. C. (1990) Negative regulation of human c-fos expression by the retinoblastoma gene product, Nature 346, 668-671.
285. Rohde, M., Warthoe, P., Gjetting, T., Lukas, J., Bartek, J. & Strauss, M. (1996) The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix, Oncogene 12, 2393-2401
286. Rustgi, A. K., Dyson, N. & Bernards, R. (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product, Nature 352, 541-544.
287. Sabbatini, P., Chiou, S. K., Rao, L. & White, E. (1995) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19 K protein, Mol. Cell. Biol. 15, 1060-1070.
288. Saenz Robles, M. T., Symonds, H., Chen, J. & Van Dyke, T. (1994) Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen, Mol. Cell Biol. 14, 2686-2698.
289. Sakai, T., Ohtani, N., McGee, T. L., Robbins, P. D. & Dryja, T. P. (1991) Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene, Nature 353, 83-86.
290. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death, Nat. Genet., in the press.
291. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A. & Weinberg, R. A. (1995) E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle, Proc. Natl Acad Sci. USA 92, 2403-2407.
292. Sarnow, P., Ho, Y. S., Williams, J. & Levine, A. J. (1982) Adenovirus E1β-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells, Cell 28, 387-394.
293. Savoysky, E., Mizuno, T., Sowa, Y., Watanabe, H., Sawada, J., Nomura, H., Ohsugi, Y. Handa, H. & Sakai, T. (1994) The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family, Oncogene 9, 1839-1846.
294. Schmidt, E. E., Ichimura, K., Reifenberger, G. & Collins, V. P. (1994) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas, Cancer Res. 54, 6321-6324.
295. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V. & Nadal Ginard, B. (1994) Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells, Science 264, 1467-1471.
296. Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen Durr, P. & Henglein, B. (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site, Proc. Natl Acad Sci. USA 92, 11 264-11 268.
297. Schwarz, J. K., Devoto, S. H., Smith, E. J., Chellappan, S. P., Jakoi, L. & Nevins, J. R. (1993) Interactions of the p107 and Rb proteins with E2F during the cell proliferation response, EMBO J. 12, 1013-1020.
298. Sehy, D. W., Shao, L. E., Yu, A. L., Tsai, W. M. & Yu, J. (1992) Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase, J. Cell. Biochem. 50, 255-265.
299. Serrano, M., Hannon, G. J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, Nature 366, 704-707.
300. Serrano, M., Lee, H., Chin, L., Cordon Cardo, C., Beach, D. & DePinho, R. A. (1996) Role of the INK4a locus in tumor suppression and cell mortality, Cell 85, 27-37.
301. Shan, B., Zhu, X., Chen, P. L., Durfee, T., Yang, Y., Sharp, D. & Lee, W. H. (1992) Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F, Mol. Cell. Biol. 12, 5620-5631.
302. Shan, B. & Lee, W. H. (1994) Deregulated expression of E2F-1 induces S phase entry and leads to apoptosis, Mol. Cell. Biol. 14, 8166-8173.
303. Shan, B., Chang, C. Y., Jones, D. & Lee, W. H. (1994) The transcription factor E2F-1 mediates the autoregulation of RB gene expression, Mol. Cell. Biol. 14, 299-309.
304. Shan, B., Durfee, T. & Lee, W. H. (1996) Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S phase entry and apoptosis, Proc. Natl Acad. Sci. USA 93, 679-684.
305. Shao, Z., Ruppert, S. & Robbins, P. D. (1995) The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250, Proc. Natl Acad. Sci. USA 92, 3115-3119.
306. Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordonez, J. V. & Fontana, J. A. (1994) Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways, Oncogene 9, 3407-3415.
307. Sherr, C. J. (1993) Mammalian G1 cyclins, Cell 73, 1059-1065.
308. Sherr, C. J. (1994) G1 phase progression: cycling on cue, Cell 79, 551-555.
309. Sherr, C. J. (1995) D-type cyclins, Trends Biochem. Sci. 20, 187-190.
310. Sherr, C. J. & Roberts, J. M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases, Genes & Dev. 9, 1149-1163.
311. Shew, J. Y. Ling, N., Yang, X. M., Fodstad, O. & Lee, W. H. (1989) Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas, Oncogene Res. 4, 205-214.
312. Shiio, Y., Sawada, J., Handa, H., Yamamoto, T. & Inoue, J. (1996) Activation of the retinoblastoma gene expression by Bcl-3: implication for muscle cell differentiation, Oncogene 12, 1837-1845.
313. Shim, J., Lee, H., Park, J., Kim, H. & Choi, E. J. (1996) A non-enzymatic p21 protein inhibitor of stress-activated protein kinases, Nature 381, 804-806.
314. Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M. & Chittenden, T. (1992) The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner, Cell 68, 157-166.
315. Singh, P., Wong, S. H. & Hong, W. (1994) Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation, EMBO J. 13, 3329-3338.
316. Skapek, S. X., Rhee, J., Spicer, D. B. & Lassar, A. B. (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase, Science 267, 1022-1024.
317. Slack, R. S., Hamel, P. A., Bladon, T. S., Gill, R. M. & McBurney, M. W. (1993) Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells, Oncogene 8, 1585-1591.
318. Slansky, J. E. & Farnham, P. J. (1996) Transcriptional regulation of the dihydrofolate reductase gene, Bioessays 18, 55-62.
319. Slebos, R. J., Lee, M. H., Plunkett, B. S., Kessis, T. D., Williams, B. O., Jacks, T., Hedrick, L., Kastan, M. B. & Cho, K. R. (1994) p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein, Proc. Natl Acad. Sci. USA 91, 5320-5324.
320. Slingerland, J. M., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. R. & Reed, S. I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells, Mol. Cell. Biol. 14, 3683-3694.
321. Sofer-Levi, Y. & Resnitzky, D. (1996) Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E, Oncogene 13, 2431-2437.
322. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A. & el Houseini, M. E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation, Oncogene 9, 3389-3396.
323. Sterner, J. M., Murata, Y., Kim, H. G., Kennett, S. B., Templeton, D. J. & Horowitz, J. M. (1995) Detection of a novel cell cycle-regulated kinase activity that associates with the amino terminus of the retinoblastoma protein in G2/M phases, J. Biol. Chem. 270, 9281-9288.
324. Sterner, J. M., Tao, Y., Kennett, S. B., Kim, H. G. & Horowitz, J. M. (1996) The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression, Cell Growth Differ. 7, 53-64
325. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2, Cell 79, 329-339.
326. Strauss, M., Hering, S., Lieber, A., Herrmann, G., Griffin, B. E. & Arnold, W. (1992) Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis, Oncogene 7, 769-773.
327. Strauss, M., Lukas, J. & Bartek, J. (1995) Unrestricted cell cycling and cancer, Nat. Med. 1, 1245-1246.
328. Symonds, H., Krall, L., Remington, L., Saenz Robles, M., Lowe, S., Jacks, T. & Van Dyke, T. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo, Cell 78, 703-711.
329. Szekely, L., Jiang, W. Q., Bulic Jakus, F., Rosen, A., Ringertz, N., Klein, G. & Wiman, K. G. (1992) Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses, Cell Growth Differ. 3, 149-156.
330. T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L. & Fung, Y. K. (1988) Structural rearrangement of the retinoblastoma gene in human breast carcinoma, Science 242, 263-266.
331. Takahashi, R., Hashimoto, T., Xu, H. J., Hu, S. X., Matsui, T., Miki, T., Bigo Marshall, H., Aaronson, S. A. & Benedict, W. F. (1991) The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells, Proc. Natl Acad. Sci. USA 88, 5257-5261.
332. Tam, S. W., Theodoras, A. M., Shay, J. W., Draetta, G. F. & Pagano,
333. Tiainen, M., Spilkovsky, D., Jansen-Durr, P., Sacchi, A. & Crescenzi, M. (1996) Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue specific genes by separable mechanisms, Mol. Cell. Biol. 16, 5302-5312.
334. Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R. & Darlington, G. J. (1996) CCAAT/Enhancer binding protein alpha C/EBP α inhibits cell proliferation through the p21 (WAF 1/CIP 1/SDI 1) protein, Genes & Dev. 10, 804-815.
335. Toguchida, J., Ishizaki, K., Sasaki, M. S., Ikenaga, M., Sugimoto, M., Kotoura, Y. & Yamamuro, T. (1988) Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma, Cancer Res. 48, 3939-3943.
336. Tommasi, S. & Pfeifer, G. P. (1995) In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression, Mol. Cell. Biol. 15, 6901-6913.
337. Toyoshima, H. & Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21, Cell 78, 67-74.
338. Tsuruta, H., Sakamoto, H., Onda, M. & Terada, M. (1993) Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas, Biochem. Biophys. Res. Commun. 196, 1529-1536.
339. Udvadia, A. J., Rogers, K. T., Higgins, P. D., Murata, Y., Martin, K. H., Humphrey, P. A. & Horowitz, J. M. (1993) Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression, Proc Natl Acad. Sci. USA 90, 3265-3269.
340. Udvadia, A. J., Templeton, D. J. & Horowitz, J. M. (1995) Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression, Proc. Natl Acad. Sci. USA 92, 3953-3957.
341. Vairapandi, M., Balliet, A. G., Fornace, A. J. Jr, Hoffman, B. & Liebermann, D. A. (1996) The differentiation primary response gne MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21 WAF1/CIP1, Oncogene 12, 2579-2594.
342. Varley, J. M., Armour, J., Swallow, J. E., Jeffreys, A. J., Ponder, B. A., T'Ang, A., Fung, Y. K., Brammar, W. J. & Walker, R. A. (1989) The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours, Oncogene 4, 725-729.
343. Vousden, K. H. (1995) Regulation of the cell cycle by viral oncoproteins, Semin. Cancer Biol. 6, 109-116.
344. Waga, S., Hannon, G. J., Beach, D. & Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA, Nature 369, 574-578.
345. Wang, C. Y., Petryniak, B., Thompson, C. B., Kaelin, W. G. & Leiden, J. M. (1993) Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblasloma protein, Science 260, 1330-1335.
346. Wang, H., Grand, R. J. A., Milner, A. E., Armitage, R. J., Gordon, J. & Gregory, C. D. (1996) Repression of apoptosis in human B lymphoma cells by CD40 ligand and BCL 2: relationship to the cell cycle and role of the retinoblastoma protein, Oncogene 13, 373-379.
347. Wang, J. & Walsh, K. (1996) Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation, Science 273, 359-361.
348. Wang, J. Y., Knudsen, E. S. & Welch, P. J. (1994) The retinoblastoma tumor suppressor protein, Adv. Cancer Res. 64, 25-85.
349. Warbrick, E., Lane, D. P., Glover, D. M. & Cox, L. S. (1995) A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen, Curr. Biol. 5, 275-282.
350. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T. & Takahashi, T. (1995) In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers, Cancer Res. 55, 514-517.
351. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control, Cell 81, 323-330.
352. Weintraub, S. J., Prater, C. A. & Dean, D. C. (1992) Retinoblastoma protein switches the E2F site from positive to negative element, Nature 358, 259-261.
353. Weintraub, S. J., Chow, K. N., Luo, R. X., Zhang, S. H., He, S. & Dean, D. C. (1995) Mechanism of active transcriptional repression by the retinoblastoma protein, Nature 375, 812-815.
354. Welch, P. J. & Wang, J. Y. (1993) A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle, Cell 75, 779-790.
355. Welch, P. J. & Wang, J. Y. (1995) Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms, Mol. Cell. Biol. 15, 5542-5551.
356. Werness, B. A., Levine, A. J. & Howley, P. M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science 248, 76-79.
357. White, E., Spector, D. & Welch, W. (1988) Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells, J. Virol. 62, 4153-4166.
358. White, A. E., Livanos, E. M. & Tlsty, T. D. (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins, Genes & Dev. 8, 666-677.
359. White, E., Cipriani, R., Sabbatini, P. & Demon, A. (1991) Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins, J. Virol. 65, 2968-2978.
360. White, E., Sabbatini, P., Debbas, M., Wold, W. S., Kusher, D. I. & Gooding, L. R. (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α, Mol. Cell. Biol. 12, 2570-2580.
361. White, E. (1996) Life, death, and the pursuit of apoptosis, Genes & Dev. 10, 1-15.
362. White, R. J., Trouche, D., Martin, K., Jackson, S. P. & Kouzarides, T. (1996) Repression of RNA polymerase III transcription by the retinoblastoma protein, Nature 382, 88-90.
363. Wimmel, A., Lucibello, F. C., Sewing, A., Adolph, S. & Müller, R. (1994) Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E, Oncogene 9, 995-997.
364. Windle, J. J., Albert, D. M., O'Brien, J. M., Marcus, D. M., Disteche, C. M., Bernards, R. & Mellon, P. L. (1990) Retinoblastoma in transgenic mice, Nature 343, 665-669.
365. Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wolfel, C., Klehmann Hieb, E., De Plaen, E., Hankein, T., Meyer zum Buschenfelde, K. H. & Beach, D. (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma, Science 269, 1281-1284.
366. Wu, C. L., Zukerberg, L. R., Ngwu, C., Harlow, E. & Lees, J. A. (1995) In vivo association of E2F and DP family proteins, Mol. Cell. Biol. 15, 2536-2546.
367. Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y. & Van Dyke, T. (1996) Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration, Genes & Dev. 10, 245-260.
368. Wu, X. & Levine, A. J. (1994) p53 and E2F-1 cooperate to mediate apoptosis, Proc. Natl Acad. Sci. USA 91, 3602-3606.
369. Xiao, Z. X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R. & Livingston, D. M. (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2, Nature 375, 694-698.
370. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R. & Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases, Nature 366, 701-704.
371. Xu, G., Livingston, D. M. & Krek, W. (1995) Multiple members of the E2F transcription factor family are the products of oncogenes, Proc. Nail Acad. Sci. USA 92, 1357-1361.
372. Xu, M., Sheppard, K. A., Peng, C. Y., Yee, A. S. & Piwnica Worms, H. (1994) Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation, Mol. Cell. Biol. 14, 8420-8431.
373. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. & Dyson, N. J. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1, Cell 85, 537-548
374. Yan, G. Z. & Ziff, E. B. (1995) NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1, J. Neurosci. 15, 6200-6212.
375. Yan, Z., Hsu, S., Winawer, S. & Friedman, E. (1992) Transforming growth factor β 1 (TGF-β 1) inhibits retinoblasloma gene expression but not pRB phosphorylation in TGF-β 1-growth stimulated colon carcinoma cells, Oncogene 7, 801-805.
376. Yen, A., Forbes, M. E., Varvayanis, S., Tykocinski, M. L., Groger, R. K. & Platko, J. D. (1993a) C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression, J. Cell. Physiol. 157, 379-391.
377. Yen, A., Varvayanis, S. & Platko, J. D. (1993b) 12-O-Tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells, Cancer Res. 53, 3085-3091.
378. Yokota, J., Akiyama, T., Fung, Y. K. T., Benedict, W. F., Namba, Y., Hanaoka, M., Wada, M., Terasaki, T., Shimosato, Y., Sugimura, T. & Terada, M. (1988) Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung, Oncogene 3, 471-475.
379. Zacksenhaus, E., Bremner, R., Phillips, R. A. & Gallie, B. L. (1993) A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity, Mol. Cell. Biol. 13, 4588-4599.
380. Zhang, H., Hannon, G. J. & Beach, D. (1994) p21-containing cyclin kinases exist in both active and inactive states, Genes & Dev. 8, 1750-1758.
381. Zhang, Y. J., Jiang, W., Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M. & Weinstein, I. B. (1993) Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma, Biochem. Biophys. Res. Commun. 196, 1010-1016.
382. Zhou, P., Jiang, W., Zhang, Y. J., Kahn, S. M., Schieren, I., Santella, R. M. & Weinstein, I. B. (1995) Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells, Oncogene 11, 571-580.
383. Zhou, Y., Li, J., Xu, K., Hu, S. X., Benedict, W. F. & Xu, H. J. (1994) Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells, Proc. Natl Acad. Sci. USA 91, 4165-4169.
384. Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N. & Harlow, E. (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein, Genes & Dev. 7, 1111-1125.
385. Zhu, L., Enders, G., Lees, J. A., Beijersbergen, R. L., Bernards, R. & Harlow, E. (1995a) The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes, EMBO J. 14, 1904-1913.
386. Zhu, L., Harlow, E. & Dynlacht, B. D. (1995b) p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F, Genes & Dev. 9, 1740-1752.
387. Zhu, L., Xie, E. & Chang, L. S. (1995c) Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins, Mol. Cell. Biol. 15, 3552-3562.
388. Zwicker, J., Liu, N., Engeland, K., Lucibello, F. C. & Müller, R. (1996) Cell cycle regulation of E2F site occupation in vivo, Science 271, 1595-1597.
389. Zwijsen, R. M., Klompmaker, R., Wientjens, E. B., Kristel, P. M., van der Burg, B. & Michalides, R. J. (1996) Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit, Mol. Cell. Biol. 16, 2554-2560.